Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

BIIB

Biogen Inc

May 03 • 03:04PM ET

216.40

Dollar change +2.89
Percentage change 1.35	%

Healthcare • Drug Manufacturers - General • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ MOAT IVV VTV IBB VOE RSP

Index	NDX, S&P 500	P/E	27.03	EPS (ttm)	8.01	Insider Own	0.80%	Shs Outstand	144.90M	Perf Week	3.59%
Market Cap	31.51B	Forward P/E	12.39	EPS next Y	17.46	Insider Trans	-0.10%	Shs Float	144.43M	Perf Month	5.41%
Income	1.17B	PEG	8.45	EPS next Q	3.98	Inst Own	90.16%	Short Float	2.26%	Perf Quarter	-11.21%
Sales	9.29B	P/S	3.39	EPS this Y	6.17%	Inst Trans	0.83%	Short Ratio	2.51	Perf Half Y	-9.69%
Book/sh	104.48	P/B	2.07	EPS next Y	11.75%	ROA	4.56%	Short Interest	3.26M	Perf Year	-30.03%
Cash/sh	7.38	P/C	29.33	EPS next 5Y	3.20%	ROE	8.04%	52W Range	189.44 - 319.76	Perf YTD	-16.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-18.05%	ROI	5.32%	52W High	-32.32%	Beta	-0.03
Dividend TTM	-	Quick Ratio	1.32	Sales past 5Y	-4.53%	Gross Margin	68.31%	52W Low	14.23%	ATR (14)	5.45
Dividend Ex-Date	-	Current Ratio	2.10	EPS Y/Y TTM	-62.75%	Oper. Margin	18.67%	RSI (14)	61.16	Volatility	3.42% 2.46%
Employees	7570	Debt/Eq	0.46	Sales Y/Y TTM	-2.49%	Profit Margin	12.56%	Recom	1.58	Target Price	285.70
Option/Short	Yes / Yes	LT Debt/Eq	0.44	EPS Q/Q	0.93%	Payout	0.00%	Rel Volume	0.56	Prev Close	213.51
Sales Surprise	-0.83%	EPS Surprise	5.78%	Sales Q/Q	-5.62%	Earnings	Apr 24 BMO	Avg Volume	1.30M	Price	216.40
SMA20	6.91%	SMA50	1.95%	SMA200	-10.60%	Trades		Volume	628,471	Change	1.35%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-24	Reiterated	Needham	Buy	$305 → $300
Feb-14-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$315 → $240
Jan-24-24	Downgrade	UBS	Buy → Neutral	$311 → $276
Dec-20-23	Resumed	Cantor Fitzgerald	Overweight	$311
Dec-07-23	Upgrade	Raymond James	Mkt Perform → Outperform	$283
Sep-06-23	Initiated	HSBC Securities	Buy	$360
Jul-27-23	Initiated	Scotiabank	Sector Outperform	$327
Jul-24-23	Reiterated	UBS	Buy	$346 → $335
May-01-23	Upgrade	Guggenheim	Neutral → Buy	$270 → $350
Apr-17-23	Upgrade	Piper Sandler	Neutral → Overweight	$280 → $346
Oct-26-22	Upgrade	Goldman	Neutral → Buy	$220 → $370
Oct-13-22	Upgrade	Stifel	Hold → Buy	$223 → $299
Oct-07-22	Upgrade	Argus	Hold → Buy	$300
Sep-28-22	Upgrade	Robert W. Baird	Neutral → Outperform	$224 → $340
Sep-28-22	Upgrade	Mizuho	Neutral → Buy	$207 → $270
Sep-28-22	Upgrade	BMO Capital Markets	Market Perform → Outperform	$217 → $360
Apr-18-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$235 → $265
Mar-08-22	Downgrade	Stifel	Buy → Hold	$304 → $223
Mar-03-22	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$227 → $248
Feb-04-22	Reiterated	Wolfe Research	Peer Perform	$244 → $217

Show Previous Ratings

Today 12:01PM	HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating (MT Newswires)
May-02-24 07:30AM	Biogen Reports Progress on Corporate Responsibility Priorities (GlobeNewswire)
Apr-30-24 11:15AM	Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts? (Investor's Business Daily)
Apr-29-24 10:03AM	7 Retirement Stocks to Buy at a 52-Week Low in April (InvestorPlace)
09:50AM	10 Most Promising Stocks to Buy Before They Take Off (Insider Monkey)
11:27AM	Loading…
Apr-26-24 11:27AM	Guggenheim Adjusts Price Target on Biogen to $255 From $275 (MT Newswires)
05:00AM	Ozempic hits booze sales, Moderna likes AI, and Biogen's blockbuster drug: Pharma news roundup (Quartz)
01:02AM	Decoding Biogen Inc (BIIB): A Strategic SWOT Insight (GuruFocus.com)
Apr-25-24 04:05PM	Biogen Receives Positive CHMP Opinion for TOFIDENCE (tocilizumab), a Biosimilar Referencing ROACTEMRA (GlobeNewswire)
02:15PM	Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:00AM	For Beaten-Down Maker of Alzheimers Drug, Good Enough Will Do (The Wall Street Journal)
01:23AM	Q1 2024 Biogen Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-24-24 06:18PM	Why Biogen Stock Leaped Nearly 5% Higher Today (Motley Fool)
04:19PM	Biogen Stock Surges After Two Notable Products Walloped Sales Expectations (Investor's Business Daily)
04:01PM	Analyst Report: Biogen Inc. (Morningstar Research)
02:12PM	Loading…
02:12PM	Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings (Benzinga)
12:57PM	Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake (Zacks)
12:45PM	Biogen (BIIB) Q1 2024 Earnings Call Transcript (Motley Fool)
12:28PM	Biogen: Dont expect any big acquisitions this year (BioPharma Dive)
11:53AM	BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
11:13AM	Biogen shares rise on sales of groundbreaking Alzheimer's drug Leqembi (Quartz)
11:08AM	Biogen Stock Rises After Earnings, Jump in Sales of Alzheimers Drug (Barrons.com)
10:39AM	To be better at neuroscience, Biogen will invest outside the therapeutic area (FierceBiotech.com)
10:28AM	Biogen stock rises on Q1 results, Alzheimer's drug sales (Yahoo Finance Video)
10:05AM	Biogen Affirms Guidance After Mixed First Quarter (MT Newswires)
09:39AM	Alzheimers Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock (The Wall Street Journal)
09:34AM	Biogen Beats Estimates as Alzheimers Drug Gains Traction (Bloomberg)
09:30AM	Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:00AM	Sector Update: Health Care Stocks Rise Pre-Bell Wednesday (MT Newswires)
08:39AM	Alzheimers Drug Leqembi Finally Sees Sales Pickup (The Wall Street Journal)
08:32AM	Loading…
08:32AM	Biogen Inc (BIIB) Q1 2024 Earnings: Mixed Results Amidst Strategic Growth Efforts (GuruFocus.com)
07:45AM	Biogen's Q1 Adjusted Earnings Rise, Revenue Falls; Reaffirms 2024 Adjusted Earnings Guidance, Shares Gain 4% Pre-Bell (MT Newswires)
07:15AM	Biogen Q1 Adj. EPS Tops Estimates, But Sales Miss; Reaffirms FY24 Outlook (RTT News)
06:48AM	Biogen cost cuts drive profit beat, Alzheimer's drug sales jump (Reuters)
06:45AM	Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline? (Investor's Business Daily)
06:45AM	Biogen beats quarterly profit estimates, Alzheimer's drug sales jump (Reuters)
Apr-23-24 12:23AM	Should You Be Confident in Biogen (BIIB)? (Insider Monkey)
Apr-19-24 09:39AM	What's in Store for Biogen (BIIB) This Earnings Season? (Zacks)
09:15AM	Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Apr-17-24 10:01AM	Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-12-24 10:00AM	Biogen Is Suffering From Doubts About the Future (GuruFocus.com)
Apr-11-24 02:15PM	Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision? (Investor's Business Daily)
Apr-10-24 06:09PM	12 Best Depressed Stocks To Buy in 2024 (Insider Monkey)
Apr-01-24 05:50PM	Biogen Inc. (BIIB) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
04:02PM	Software Acquisition Group Inc. III (NASDAQ:SWAG) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-31-24 07:30PM	Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA (PR Newswire)
11:53AM	12 Best S&P 500 Stocks To Buy According to Analysts (Insider Monkey)
Mar-28-24 08:00AM	Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback (Investor's Business Daily)
Mar-27-24 12:18PM	Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-26-24 11:21AM	CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug (Zacks)
Mar-25-24 05:50PM	Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know (Zacks)
Mar-22-24 07:05AM	UPDATE 3-EU regulator delays decision on Eisai-Biogen Alzheimer's drug (Reuters)
06:57AM	EU drug regulator does not refer to Eisai-Biogen Alzheimer's drug in meeting notes (Reuters)
Mar-21-24 05:14PM	Hedge Funds and Insiders Are Buying These 10 Stocks (Insider Monkey)
09:17AM	Biogen, Moderna, and 6 More Healthcare Stocks That Wall Street Thinks Have Upside (Barrons.com)
04:39AM	Biogen, Moderna, and 6 More Healthcare Stocks With Room to Grow (Barrons.com)
Mar-18-24 05:50PM	Here's Why Biogen Inc. (BIIB) Gained But Lagged the Market Today (Zacks)
10:16AM	25 Most Stressed Cities in the United States (Insider Monkey)
Mar-15-24 09:34AM	Biogen's CMO Maha Radhakrishnan departs, leaving behind a legacy in Alzheimer's drug development (FierceBiotech.com)
Mar-14-24 11:30AM	Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report? (Zacks)
Mar-12-24 05:50PM	Biogen Inc. (BIIB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Mar-11-24 12:44PM	20 Highest Paying Countries for Biotechnology (Insider Monkey)
09:00AM	AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions (Business Wire)
Mar-08-24 04:11PM	FDA delays approval deadline for Eli Lilly's Alzheimer's drug (Yahoo Finance Video)
04:07PM	Three-Stock Lunch: Biogen, DocuSign (CNBC TV)
02:48PM	Top Stock Movers Now: Broadcom, Costco, MongoDB, and More (Investopedia)
02:38PM	Eli Lilly's Alzheimer's Drug Release Delayed for FDA Investigation (Investopedia)
11:44AM	FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug (Associated Press Finance)
10:58AM	Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision (Benzinga)
10:52AM	Eli Lilly Alzheimers Drug Delayed as FDA Plans Advisory Panel Meeting (The Wall Street Journal)
10:20AM	Amylyxs ALS Drug Fails Trial, Raising Questions About Companys Future (Barrons.com)
Mar-07-24 09:31AM	Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline (FierceBiotech.com)
Mar-06-24 05:45PM	Biogen Inc. (BIIB) Gains But Lags Market: What You Should Know (Zacks)
07:30AM	New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy (GlobeNewswire)
Mar-05-24 05:50PM	Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market (Zacks)
08:33AM	After tough rightsizing, Biogen looks to newer rare diseases to broaden lens (FierceBiotech.com)
Mar-04-24 04:15PM	Biogen Highlights New Data at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD ) 2024 Annual Meeting (GlobeNewswire)
Mar-02-24 04:53AM	1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223? (Motley Fool)
Mar-01-24 01:45PM	Is Eli Lilly Stock A Buy On Projection For $81 Billion In Weight-Loss Sales? (Investor's Business Daily)
Feb-28-24 05:45PM	Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market (Zacks)
Feb-25-24 07:04AM	14 Best Beaten Down Stocks To Buy Right Now (Insider Monkey)
Feb-23-24 12:44PM	Is Eli Lilly Stock A Buy As Amgen Enters The Red-Hot Weight-Loss Ring? (Investor's Business Daily)
07:00AM	Biogen's QALSODY (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP (GlobeNewswire)
06:14AM	UPDATE 2-EU medicines regulator backs Biogen's ALS drug (Reuters)
05:56AM	EU medicines regulator backs Biogen's ALS drug (Reuters)
Feb-20-24 11:21AM	20 Most Sustainable Companies in the US (Insider Monkey)
Feb-19-24 01:46PM	From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024 (InvestorPlace)
Feb-15-24 04:13PM	7 Contrarian Biotech Stocks to Consider Amid Sector Weakness (InvestorPlace)
Feb-14-24 05:11PM	Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says (Benzinga)
09:11AM	Biogen Inc. (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:42AM	Sage offers details on launch of new postpartum depression pill (BioPharma Dive)
06:37AM	UPDATE 2-Biogen gets DOJ subpoena on business operations in foreign countries (Reuters)
06:18AM	Biogen receives subpoena from DOJ on business operations in foreign countries (Reuters)
01:35AM	Q4 2023 Biogen Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-13-24 04:34PM	Analyst Report: Biogen Inc. (Morningstar Research) -7.39%
02:45PM	Biogen (BIIB) Q4 2023 Earnings Call Transcript (Motley Fool)
01:09PM	PRIMECAP Management Bolsters Stake in Biogen Inc (GuruFocus.com)
12:53PM	Biogen Plunges as Alzheimer Drugs Slow Uptake Signals Reset (Bloomberg)
11:44AM	Biogen Tumbles as Drug Closeout Costs, Multiple Sclerosis Medicine Sales Weigh on Profit (Investopedia)
11:17AM	Biogen (BIIB) Q4 Earnings & Sales Miss Estimates, Stock Falls (Zacks)

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singhal Priya	Head of Development	Apr 02 '24	Sale	213.09	93	19,817	4,886	Apr 03 08:24 PM
Murphy Nicole	Head of Pharm Ops and Tech	Apr 01 '24	Option Exercise	0.00	240	0	9,751	Apr 03 08:11 PM
Singhal Priya	Head of Development	Feb 22 '24	Sale	221.23	262	57,962	4,886	Feb 26 07:54 PM
Singhal Priya	Head of Development	Feb 16 '24	Option Exercise	0.00	1,208	0	5,429	Feb 21 09:27 PM
ALEXANDER SUSAN H	EVP Chief Legal Officer	Feb 16 '24	Option Exercise	0.00	5,037	0	52,506	Feb 21 09:39 PM
Gregory Ginger	EVP, Human Resources	Feb 16 '24	Option Exercise	0.00	4,704	0	14,341	Feb 21 09:36 PM
Izzar Rachid	Head of Global Product Strat.	Feb 16 '24	Option Exercise	0.00	2,017	0	10,014	Feb 21 09:33 PM
Kramer Robin	Chief Accounting Officer	Feb 16 '24	Option Exercise	0.00	1,345	0	6,354	Feb 21 09:31 PM
MCDONNELL MICHAEL R	EVP, Chief Financial Officer	Feb 16 '24	Option Exercise	0.00	6,720	0	20,692	Feb 21 09:29 PM
Murphy Nicole	Head of Pharm Ops and Tech	Feb 16 '24	Option Exercise	0.00	1,260	0	9,624	Feb 21 09:28 PM
Singhal Priya	Head of Development	Feb 16 '24	Sale	221.49	108	23,921	5,148	Feb 21 09:27 PM
Rowinsky Eric K	Director	Feb 15 '24	Buy	222.54	455	101,256	20,629	Feb 20 09:13 PM
Singhal Priya	Head of Development	Feb 12 '24	Sale	239.45	419	100,330	4,516	Feb 13 06:06 PM
Singhal Priya	Head of Development	Feb 09 '24	Option Exercise	0.00	1,212	0	5,309	Feb 13 06:06 PM
Murphy Nicole	Head of Pharm Ops and Tech	Feb 09 '24	Option Exercise	0.00	2,272	0	9,529	Feb 13 06:04 PM
MCDONNELL MICHAEL R	EVP, Chief Financial Officer	Feb 09 '24	Option Exercise	0.00	3,257	0	17,555	Feb 13 06:03 PM
Kramer Robin	Chief Accounting Officer	Feb 09 '24	Option Exercise	0.00	833	0	5,523	Feb 13 06:01 PM
Gregory Ginger	EVP, Human Resources	Feb 09 '24	Option Exercise	0.00	2,158	0	11,778	Feb 13 06:14 PM
ALEXANDER SUSAN H	EVP Chief Legal Officer	Feb 09 '24	Option Exercise	0.00	2,575	0	50,021	Feb 13 05:56 PM
Izzar Rachid	Head of Global Product Strat.	Feb 09 '24	Option Exercise	0.00	1,515	0	9,081	Feb 13 06:00 PM
MCDONNELL MICHAEL R	EVP, Chief Financial Officer	Feb 08 '24	Option Exercise	0.00	2,335	0	15,063	Feb 09 08:03 PM
Murphy Nicole	Head of Pharm Ops and Tech	Feb 08 '24	Option Exercise	0.00	2,101	0	7,895	Feb 09 08:01 PM
Kramer Robin	Chief Accounting Officer	Feb 08 '24	Option Exercise	0.00	788	0	4,943	Feb 09 08:06 PM
Gregory Ginger	EVP, Human Resources	Feb 08 '24	Option Exercise	0.00	1,635	0	10,118	Feb 09 08:14 PM
Izzar Rachid	Head of Global Product Strat.	Feb 08 '24	Option Exercise	0.00	2,043	0	8,187	Feb 09 08:11 PM
ALEXANDER SUSAN H	EVP Chief Legal Officer	Feb 08 '24	Option Exercise	0.00	2,190	0	48,101	Feb 09 08:16 PM
Singhal Priya	Head of Development	Feb 02 '24	Sale	245.93	634	155,920	4,097	Feb 05 06:38 PM
Singhal Priya	Head of Development	Feb 01 '24	Option Exercise	0.00	1,828	0	5,292	Feb 05 06:38 PM
Singhal Priya	Head of Development	Dec 11 '23	Sale	248.00	110	27,280	3,464	Dec 12 05:06 PM
Kramer Robin	Chief Accounting Officer	Dec 08 '23	Option Exercise	0.00	351	0	4,325	Dec 12 05:02 PM
Singhal Priya	Head of Development	Dec 08 '23	Option Exercise	0.00	426	0	3,780	Dec 12 05:06 PM
BIOGEN INC.	10% Owner	Sep 26 '23	Sale	0.50	6,000,000	3,000,000	17,652,466	Sep 28 05:30 PM
Singhal Priya	Head of Development	Sep 05 '23	Sale	269.43	431	116,124	3,354	Sep 06 06:06 PM
MCDONNELL MICHAEL R	EVP, Chief Financial Officer	Sep 01 '23	Option Exercise	0.00	5,285	0	14,060	Sep 06 06:08 PM
Singhal Priya	Head of Development	Sep 01 '23	Option Exercise	0.00	1,668	0	4,592	Sep 06 06:06 PM
Singhal Priya	Head of Development	Jul 03 '23	Sale	282.87	81	22,912	2,924	Jul 05 05:33 PM
Singhal Priya	Head of Development	Jun 30 '23	Option Exercise	0.00	315	0	3,158	Jul 05 05:33 PM
Izzar Rachid	Head of Global Product Strat.	Jun 30 '23	Option Exercise	0.00	504	0	6,388	Jul 05 05:37 PM
Kramer Robin	Chief Accounting Officer	Jun 30 '23	Option Exercise	0.00	252	0	4,096	Jul 05 05:35 PM

Open in Screener

ILMN

Illumina Inc

May 03 • 03:04PM ET

120.08

Dollar change -3.91
Percentage change -3.16	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ VUG IVV VOT IBB RSP VHT

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-8.15	Insider Own	0.50%	Shs Outstand	159.00M	Perf Week	-1.80%
Market Cap	19.08B	Forward P/E	47.13	EPS next Y	2.55	Insider Trans	0.89%	Shs Float	158.10M	Perf Month	-4.70%
Income	-1290.00M	PEG	-	EPS next Q	0.09	Inst Own	93.55%	Short Float	3.34%	Perf Quarter	-16.73%
Sales	4.49B	P/S	4.25	EPS this Y	-9.54%	Inst Trans	2.72%	Short Ratio	3.25	Perf Half Y	12.58%
Book/sh	36.13	P/B	3.32	EPS next Y	227.48%	ROA	-11.81%	Short Interest	5.27M	Perf Year	-38.90%
Cash/sh	6.97	P/C	17.22	EPS next 5Y	22.90%	ROE	-20.76%	52W Range	89.00 - 213.91	Perf YTD	-13.76%
Dividend Est.	-	P/FCF	67.66	EPS past 5Y	-	ROI	-16.28%	52W High	-43.87%	Beta	1.24
Dividend TTM	-	Quick Ratio	1.36	Sales past 5Y	7.40%	Gross Margin	69.64%	52W Low	34.92%	ATR (14)	4.97
Dividend Ex-Date	-	Current Ratio	1.75	EPS Y/Y TTM	73.83%	Oper. Margin	-1.62%	RSI (14)	41.14	Volatility	3.27% 3.62%
Employees	12010	Debt/Eq	0.38	Sales Y/Y TTM	1.03%	Profit Margin	-28.71%	Recom	2.46	Target Price	151.55
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-4270.53%	Payout	-	Rel Volume	1.49	Prev Close	123.99
Sales Surprise	2.44%	EPS Surprise	109.79%	Sales Q/Q	-1.01%	Earnings	May 02 AMC	Avg Volume	1.62M	Price	120.08
SMA20	-3.12%	SMA50	-7.85%	SMA200	-12.60%	Trades		Volume	2,094,104	Change	-3.16%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250
Aug-25-22	Initiated	Credit Suisse	Neutral	$230
Jul-13-22	Downgrade	Barclays	Equal Weight → Underweight	$350 → $150

Show Previous Ratings

Today 11:55AM	Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:46AM	Bernstein Adjusts Illumina's Price Target to $130 From $129 (MT Newswires)
10:46AM	TD Cowen Adjusts Illumina's Price Target to $140 From $150 (MT Newswires)
10:20AM	Baird Raises Price Target on Illumina to $128 From $125 (MT Newswires)
09:39AM	Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens (Zacks)
09:25AM	Loading…
09:25AM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
09:18AM	Evercore ISI Adjusts Price Target on Illumina to $195 From $200 (MT Newswires)
07:16AM	Q1 2024 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
06:55AM	Leerink Adjusts Price Target on Illumina to $150 From $155 (MT Newswires)
04:12AM	Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-02-24 09:46PM	Analyst Report: Illumina, Inc. (Morningstar Research)
08:56PM	ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Illumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
06:25PM	Illumina reaffirms annual revenue forecast over continued sluggish demand (Reuters)
05:35PM	Illumina Inc (ILMN) Q1 Earnings: Navigating Through Challenges with Mixed Results (GuruFocus.com)
05:21PM	Loading…
05:21PM	Illumina Q1 Non-GAAP Earnings Increase, Revenue Decreases -- Shares Down After Hours (MT Newswires)
04:17PM	Illumina: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 (PR Newswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 09:09PM	Lightning Round: Illumina is a good company that's poorly run, says Jim Cramer (CNBC TV)
12:45PM	Inspiring Young Minds: HRH the Princess Royal Helps Illumina Celebrate DNA Day (ACCESSWIRE)
09:16AM	Gear Up for Illumina (ILMN) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Apr-26-24 06:03AM	Shein to face tougher online content rules as EU designates it as very large online platform (Reuters)
Apr-25-24 10:02AM	Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:53AM	20 Countries with the Highest Rates of Stomach Cancer in the World (Insider Monkey)
Apr-21-24 08:30AM	This CEO has battled billionaire activist Carl Icahn twice here's his advice to Disney CEO Bob Iger (Yahoo Finance)
Apr-19-24 02:05PM	20 Countries with the Highest Cancer Survival Rates in the World (Insider Monkey)
12:10PM	Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive? (Zacks)
Apr-18-24 01:30PM	Engineering a Cool Career in Biotech - and Volunteering Along the Way (ACCESSWIRE)
08:00AM	QQQ Has Some Inexpensive Growth Stocks (ETF Trends)
09:30AM	Loading…
Apr-17-24 09:30AM	Evidence Supports Sequencing As First-Line Rare Disease Diagnostic (ACCESSWIRE)
Apr-15-24 05:40AM	European Commission approves Illuminas proposed Grail split (MedTech Dive)
Apr-12-24 09:00AM	Illumina's planned divestment of GRAIL approved by the European Commission (PR Newswire)
06:21AM	UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
05:49AM	EU approves Illumina's plan to divest cancer test maker Grail (Reuters)
Apr-10-24 08:16AM	Search for Cancer Blood Test Continues Despite Illumina-Grail Deals Failure (Barrons.com)
Apr-09-24 11:37PM	Illumina CFO steps down amid executive shakeup (MedTech Dive)
05:28PM	UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:32PM	Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:28PM	CORRECTED-UPDATE 1-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed (Reuters)
04:18PM	CORRECTED-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra named successor (Reuters)
04:05PM	Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer (PR Newswire)
Apr-05-24 02:27PM	Nasdaqs Nosebleed Section: 3 Expensive Stocks to Sell Before Its Too Late (InvestorPlace)
12:45PM	Why More Clinical Labs Are Turning to Whole-Genome Sequencing for Cancer (ACCESSWIRE)
Apr-04-24 05:00PM	Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 (PR Newswire)
Apr-02-24 09:45AM	Giving Students a New Window on Genomic Technologies (ACCESSWIRE)
Mar-30-24 07:43PM	20 Foods To Reduce Cancer Risk (Insider Monkey)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 06:17AM	Court adviser sides with Illumina in EU row that triggered Grail fine (MedTech Dive)
Mar-21-24 06:37PM	Why Illumina Stock Zoomed Higher on Thursday (Motley Fool)
05:44AM	UPDATE 2-EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:12AM	EU merger powers may be curbed after court adviser backs Illumina fight (Reuters)
05:01AM	EU court should back Illumina's appeal against EU review of Grail deal, court adviser says (Reuters)
Mar-18-24 12:40PM	A Biobank for the Americas and a Genomics Lab Power Precision Health for All (ACCESSWIRE)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Mar-13-24 06:43AM	10 Biggest Stocks Targeted By Activist Investors Right Now (Insider Monkey)
Mar-12-24 04:50PM	S&P 500 Gains and Losses Today: Oracle Surges as Results Show AI Advancement (Investopedia)
02:41PM	Carl Icahn Drops Plans for New Proxy Fight at Illumina (Bloomberg)
01:57PM	Exclusive-Icahn drops Illumina board challenge threat, sources say (Reuters)
Mar-08-24 08:45AM	Finding the Needle in the Genomic Haystack With DRAGEN (ACCESSWIRE)
Mar-07-24 03:00PM	3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise (InvestorPlace)
08:45AM	Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World (ACCESSWIRE)
Mar-02-24 02:30PM	FTC's suit against Kroger-Albertsons merger will have a 'chilling effect' on M&A activity (Yahoo Finance)
Feb-28-24 05:52AM	Reasons for the Decline of Illumina (ILMN) (Insider Monkey)
Feb-27-24 03:40AM	Do You Believe in the Growth Prospects of Illumina (ILMN)? (Insider Monkey)
03:09AM	Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China (PR Newswire)
Feb-26-24 06:29PM	Why Illumina Stock Mashed the Market on Monday (Motley Fool)
11:00AM	Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares (GuruFocus.com)
Feb-24-24 06:50AM	15 Best Shareholder Activism Law Firms (Insider Monkey)
Feb-23-24 07:59AM	Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024 (InvestorPlace)
Feb-21-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Icahn Enterprises L.P. Announces Management & Financial Update (PR Newswire)
Feb-20-24 10:25AM	Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe (Zacks)
Feb-14-24 07:00PM	Illumina, already facing pressure from Icahn, saw other activists at year end (Reuters) +5.23%
09:40AM	Illumina Named One of Americas Most JUST Companies and Included in the 2024 S&P Global Sustainability Yearbook (ACCESSWIRE)
Feb-09-24 11:19AM	Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:52AM	Q4 2023 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
07:39AM	Illumina (ILMN) Q4 Earnings Surpass Estimates, Margin Down (Zacks)
05:45AM	Illumina cut 12% of global staff over past year: CEO (MedTech Dive)
01:32AM	Analyst Report: Illumina, Inc. (Morningstar Research)
Feb-08-24 06:30PM	Illumina (ILMN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:24PM	Illumina forecasts flat 2024 sales as sluggish demand drags on (Reuters)
04:34PM	Illumina Inc (ILMN) Reports Mixed Fiscal Year 2023 Results Amidst GRAIL Divestiture (GuruFocus.com)
04:24PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
09:14AM	Illumina to lay off 111 people at San Diego headquarters (MedTech Dive)
Feb-05-24 09:16AM	Seeking Clues to Illumina (ILMN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-01-24 09:10PM	Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements (InvestorPlace)
Jan-30-24 07:31AM	Illumina (ILMN) Leads the Market With 80% Share (Insider Monkey)
Jan-29-24 07:49PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Jan-28-24 09:25AM	3 Stocks to Buy for the Age of Personalized Medicine (InvestorPlace)
Jan-23-24 08:45PM	Cramer's Lightning Round: Fluor, Illumina and Ferrari (CNBC TV)
Jan-19-24 08:25AM	Heres Why Polen Focus Growth Sold Illumina (ILMN) (Insider Monkey)
Jan-18-24 07:52AM	Here's How the New AI Algorithm Helps Illumina (ILMN) (Insider Monkey)
05:04AM	The Top 3 Stocks in the High-Potential Cancer Testing Market (InvestorPlace)
Jan-17-24 12:04PM	7 Mighty Healthcare Stocks Changing the Game of Medicine (InvestorPlace)
Jan-16-24 10:11AM	Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results (Zacks)
Jan-15-24 07:00AM	Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world (PR Newswire)
Jan-12-24 09:45AM	What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage (ACCESSWIRE)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM
Hoyt Aimee L	SVP, Chief People Officer	Nov 07 '23	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22 '23	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jul 24 '23	Sale	190.08	500	95,040	46,022	Jul 26 06:14 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jun 22 '23	Sale	200.00	500	100,000	46,522	Jun 26 05:23 PM
EPSTEIN ROBERT S	Director	May 25 '23	Option Exercise	71.09	7,600	540,284	14,764	May 25 04:34 PM

Open in Screener

DUK

Duke Energy Corp.

May 03 • 03:04PM ET

99.96

Dollar change +0.65
Percentage change 0.65	%

Utilities • Utilities - Regulated Electric • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO IVV VTV VPU USMV VYM DGRO IWD HDV

Index	S&P 500	P/E	27.10	EPS (ttm)	3.69	Insider Own	0.15%	Shs Outstand	771.00M	Perf Week	2.30%
Market Cap	77.12B	Forward P/E	15.80	EPS next Y	6.33	Insider Trans	-0.47%	Shs Float	770.27M	Perf Month	4.00%
Income	2.84B	PEG	3.95	EPS next Q	1.38	Inst Own	65.97%	Short Float	1.10%	Perf Quarter	3.89%
Sales	29.06B	P/S	2.65	EPS this Y	7.30%	Inst Trans	0.18%	Short Ratio	2.83	Perf Half Y	11.64%
Book/sh	61.15	P/B	1.63	EPS next Y	6.07%	ROA	2.33%	Short Interest	8.50M	Perf Year	2.70%
Cash/sh	0.43	P/C	234.39	EPS next 5Y	6.86%	ROE	8.67%	52W Range	83.06 - 100.56	Perf YTD	3.01%
Dividend Est.	4.19 (4.19%)	P/FCF	-	EPS past 5Y	7.61%	ROI	2.32%	52W High	-0.60%	Beta	0.44
Dividend TTM	4.08 (4.08%)	Quick Ratio	0.49	Sales past 5Y	3.69%	Gross Margin	29.26%	52W Low	20.35%	ATR (14)	1.62
Dividend Ex-Date	Feb 15, 2024	Current Ratio	0.74	EPS Y/Y TTM	10.82%	Oper. Margin	24.44%	RSI (14)	63.31	Volatility	1.70% 1.64%
Employees	27037	Debt/Eq	1.64	Sales Y/Y TTM	-0.26%	Profit Margin	9.78%	Recom	2.10	Target Price	103.90
Option/Short	Yes / Yes	LT Debt/Eq	1.49	EPS Q/Q	306.70%	Payout	74.71%	Rel Volume	0.54	Prev Close	99.31
Sales Surprise	-0.35%	EPS Surprise	-1.62%	Sales Q/Q	-1.89%	Earnings	May 07 BMO	Avg Volume	3.00M	Price	99.96
SMA20	3.11%	SMA50	4.90%	SMA200	7.41%	Trades		Volume	1,396,008	Change	0.65%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-24	Downgrade	BofA Securities	Buy → Neutral	$105 → $96
Jan-23-24	Upgrade	Evercore ISI	In-line → Outperform	$90 → $108
Jan-10-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$101 → $113
Nov-30-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$94 → $103
Aug-23-23	Initiated	Barclays	Overweight	$96
Jun-08-23	Initiated	Goldman	Neutral	$99
Mar-17-23	Upgrade	Seaport Research Partners	Sell → Neutral
Nov-21-22	Downgrade	Seaport Research Partners	Neutral → Sell	$91
Aug-05-22	Downgrade	Credit Suisse	Outperform → Neutral	$112 → $114
Jun-30-22	Downgrade	UBS	Buy → Neutral	$122 → $112
Apr-26-22	Initiated	Credit Suisse	Outperform	$125
Mar-22-22	Initiated	Citigroup	Buy	$120
Feb-14-22	Upgrade	BofA Securities	Neutral → Buy	$108 → $110
Jan-07-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$68
Aug-20-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$109
Aug-06-21	Downgrade	Vertical Research	Buy → Hold
Jul-14-21	Resumed	Credit Suisse	Neutral	$105
Jun-25-21	Upgrade	Argus	Hold → Buy	$106
Feb-12-21	Downgrade	BofA Securities	Buy → Neutral	$94
Jan-29-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$106

Show Previous Ratings

Today 09:25AM	People Behind the Power: What To Know About the Remarkable Role of Duke Energy Lineworkers (ACCESSWIRE)
May-02-24 10:29AM	Duke Energy (DUK) to Post Q1 Earnings: What's in the Offing? (Zacks)
May-01-24 06:00AM	3 ETFs to Buy When the Market Gets Crazy (InvestorPlace)
Apr-30-24 10:01AM	Duke Energy (DUK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:45AM	Duke Energy Celebrates Earth Day With $500,000 in Grants To Boost Environmental Resiliency Across North Carolina (ACCESSWIRE)
06:15PM	Loading…
Apr-29-24 06:15PM	Duke Energy (DUK) Outperforms Broader Market: What You Need to Know (Zacks)
04:30PM	Duke Energy Florida's Tree Care Practices Prevent Outages, Earn 18th Consecutive Year of National Recognition (ACCESSWIRE)
12:01PM	Duke Energy's Midwest Lineman's Rodeo qualifies 15 local lineworkers to compete in international event (PR Newswire)
09:00AM	How Big Data Centers Are Slowing the Shift to Clean Energy (The Wall Street Journal)
08:30AM	Duke Energy completes multiyear unit upgrades at Bad Creek to support the Carolinas' growing electricity demand (PR Newswire)
Apr-28-24 11:26AM	7 Utility Stocks Built to Withstand Market Mayhem (InvestorPlace)
Apr-27-24 01:03PM	30 Cities with the Highest Number of Veterans in the US (Insider Monkey)
Apr-25-24 02:15PM	Duke Energy's Annual Impact Report Shares Progress Toward a Cleaner Tomorrow That Includes Affordability and Reliability (ACCESSWIRE)
Apr-24-24 10:05AM	Duke Energy's annual Impact Report shares progress toward a cleaner tomorrow that includes affordability and reliability (PR Newswire)
08:45AM	Coastal Conservation Association Florida, the Duke Energy Mariculture Center and the FWC Continue Redfish Restocking Efforts Along West Coast (ACCESSWIRE)
08:57AM	Loading…
Apr-23-24 08:57AM	Duke Energy to hold annual shareholders meeting online May 9 (PR Newswire)
Apr-22-24 06:00PM	Duke Energy (DUK) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:33AM	Duke Energy celebrates Earth Day with $500,000 in grants to boost environmental resiliency across North Carolina (PR Newswire)
Apr-19-24 01:30PM	Duke Energy Florida's tree care practices prevent outages, earn 18th consecutive year of national recognition (PR Newswire)
Apr-18-24 06:15PM	Why the Market Dipped But Duke Energy (DUK) Gained Today (Zacks)
04:00PM	Coastal Second Harvest Food Bank Awarded Grant From Duke Energy Foundation (ACCESSWIRE)
Apr-16-24 02:34PM	People behind the power: What to know about the remarkable role of Duke Energy lineworkers (PR Newswire)
08:45AM	Duke Energy Celebrates Its Indigenous Employee Resource Group and Sponsors Campbell University's Inaugural American Indian Leadership Development Program (ACCESSWIRE)
Apr-15-24 08:30AM	As storm season begins, Duke Energy reminds public to move over, slow down as they approach utility crews working along the roadside (PR Newswire)
Apr-12-24 06:15PM	Duke Energy (DUK) Stock Moves -0.41%: What You Should Know (Zacks)
Apr-11-24 10:45AM	Duke Energy celebrates Florida lineworkers of the past, present and future ahead of National Lineworker Appreciation Day (PR Newswire)
09:10AM	Duke Energy (DUK) Unveils PowerPair Program in North Carolina (Zacks)
08:45AM	Advancing the Future of Energy With Person County, NC (ACCESSWIRE)
08:00AM	Duke Energy to announce first-quarter financial results on May 7 (PR Newswire)
Apr-09-24 08:30AM	Duke Energy Celebrates Opening Day With the Tampa Bay Rays by Pledging To Raise Funds for Florida Customers Facing Financial Hardships (ACCESSWIRE)
10:39AM	Loading…
Apr-08-24 10:39AM	Duke Energy Florida to reduce rates for a second time this year, beginning this June (PR Newswire)
Apr-05-24 06:00PM	Duke Energy (DUK) Stock Sinks As Market Gains: What You Should Know (Zacks)
Apr-04-24 04:05PM	Duke Energy to sell stake in Pioneer Transmission joint venture to John Laing (PR Newswire)
02:18PM	Duke Energy to implement new PowerPair pilot program for pairing home solar installations with battery energy storage (PR Newswire)
12:43PM	A stronger electric grid, enhanced customer services and environmental obligations are some of the drivers of Duke Energy's Indiana rate request (PR Newswire)
08:55AM	We Celebrated International Women's Day and Women in Construction Week With LaToya Faustin and She Built This City (ACCESSWIRE)
Apr-02-24 10:18AM	Duke Energy Florida files for new base rates; announces fuel filing to reduce rates in 2024, expects overall lower customer bills in 2025 (PR Newswire)
09:15AM	How Duke Energy Plans To Power the Carolinas' Energy Growth (ACCESSWIRE)
Apr-01-24 06:15PM	Here's Why Duke Energy (DUK) Fell More Than Broader Market (Zacks)
05:19PM	Piedmont Natural Gas files rate adjustment in North Carolina for capital investments to better serve customers (PR Newswire)
09:00AM	Know what's below - Piedmont Natural Gas, Duke Energy remind customers and professional excavators to call 811 before digging (PR Newswire)
Mar-28-24 09:30AM	Duke Energy and Piedmont Natural Gas Celebrate Natural Gas Employees on Natural Gas Utility Workers' Day (ACCESSWIRE)
09:00AM	Duke Energy Corporation (DUK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-27-24 05:20PM	12 Most Undervalued Renewable Energy Stocks To Buy According To Analysts (Insider Monkey)
01:45PM	Duke Energy celebrates Opening Day with the Tampa Bay Rays by pledging to raise funds for Florida customers facing financial hardships (PR Newswire)
Mar-26-24 09:29PM	20 States That Produce the Most Renewable Energy in the US (Insider Monkey)
06:15PM	Duke Energy (DUK) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
02:40PM	Duke Energy's Carolinas Lineman's Rodeo qualifies 30 local lineworkers to compete in international event (PR Newswire)
09:15AM	Duke Energy Supports Florida Customers With $150,000 in Grants to Programs Aimed at Providing Stability (ACCESSWIRE)
Mar-22-24 12:09PM	Duke Energy Progress looks to add solar power in eastern South Carolina as part of diverse plan to support booming growth (PR Newswire)
11:01AM	Xos, Inc. (NASDAQ:XOS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-20-24 06:00PM	Duke Energy (DUK) Advances But Underperforms Market: Key Facts (Zacks)
Mar-19-24 09:05AM	Duke Energy North Carolina Coal Plant Employees Give Back to Surrounding Communities With Nearly $60,000 in Grants to Area Nonprofits (ACCESSWIRE)
Mar-18-24 09:29AM	Duke Energy and Piedmont Natural Gas celebrate natural gas employees on Natural Gas Utility Workers' Day (PR Newswire)
Mar-15-24 02:47PM	Montauk Renewables, Inc. (NASDAQ:MNTK) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:33AM	Duke Energy appoints Harry Sideris president of company (PR Newswire)
Mar-14-24 10:25AM	Duke Energy supports Florida customers with $150,000 in grants to programs aimed at providing stability (PR Newswire)
09:00AM	Duke Energy Corporation (DUK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:45AM	Making Bold Moves Toward a Strong, Vibrant Community (ACCESSWIRE)
Mar-13-24 09:57AM	20 Biggest Natural Gas Companies in the World (Insider Monkey)
07:00AM	Bidens 15% Corporate Minimum Tax Hits KKR, Blackstone, Whirlpool in First Year (The Wall Street Journal)
Mar-12-24 09:30AM	Duke Energy (DUK) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
08:00AM	Duke Energy Supports First Responders in South Carolina With $500,000 in Grant Opportunities for Emergency Preparedness (ACCESSWIRE)
Mar-07-24 07:30AM	Duke Energy Supports Fellow First Responders With More Than $200,000 in Grants for Emergency Preparedness in Indiana (ACCESSWIRE)
Mar-06-24 03:43PM	Analyst Report: Duke Energy Corporation (Morningstar Research)
Mar-05-24 01:27PM	Duke Energy's Florida Lineman's Rodeo qualifies 15 local lineworkers to compete in international event (PR Newswire)
08:15AM	How Duke Energy Manages EV Charging, Helps Customers Save (ACCESSWIRE)
Feb-29-24 09:00AM	Investors Heavily Search Duke Energy Corporation (DUK): Here is What You Need to Know (Zacks)
08:20AM	Duke Energy Reflects on Black History Month (ACCESSWIRE)
Feb-27-24 11:07AM	Duke Energy supports first responders with $500,000 in grant opportunities for emergency preparedness in South Carolina (PR Newswire)
09:15AM	Her Family Was Active in the Civil Rights Movement. Now She Aims To Lift Up Black History (ACCESSWIRE)
Feb-23-24 08:30AM	Duke Energy Celebrates Black History Month With $75,000 in Grants Supporting Community and Cultural Programs in South Carolina (ACCESSWIRE)
Feb-22-24 08:30AM	Duke Energy Named One of the World's Most Admired Companies, Thanks to Its Commitment to Innovation, Sustainable Business and More (ACCESSWIRE)
Feb-20-24 08:30AM	Duke Energy Named as One of America's Most JUST Companies, Putting Customers and Employees at the Heart of Its Clean Energy Transition (ACCESSWIRE)
Feb-16-24 09:55AM	Reasons to Add Duke Energy (DUK) to Your Portfolio Right Now (Zacks)
Feb-15-24 10:09AM	Duke Energy celebrates Black History Month with $75,000 in grants supporting community and cultural programs in South Carolina (PR Newswire)
09:23AM	Duke Energy supports fellow first responders with more than $200,000 in grants for emergency preparedness in Indiana (PR Newswire)
Feb-13-24 08:45AM	Duke Energy Launches EV Charger Rental Program in North Carolina (ACCESSWIRE)
Feb-09-24 10:34AM	Duke Energy named one of the World's Most Admired Companies, thanks to its commitment to innovation, sustainable business and more (PR Newswire)
10:27AM	Duke Energy Corporation (NYSE:DUK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-08-24 12:26PM	Analyst Report: Duke Energy Corporation (Morningstar Research)
12:08PM	Duke Energy (DUK) Q4 Earnings Miss Estimates, Revenues Fall (Zacks)
08:45AM	Where People Can Turn When They Need Help Paying Utility Bills (ACCESSWIRE)
06:54AM	Duke Energy reports fourth-quarter and full-year 2023 financial results (PR Newswire)
Feb-07-24 12:44PM	Duke Energy shares ways to save energy and money as winter temperatures in Florida continue to fluctuate (PR Newswire)
Feb-06-24 01:30PM	Duke Energy named as one of America's Most JUST Companies, putting customers and employees at the heart of its clean energy transition (PR Newswire)
08:15AM	Duke Energy's Rebates Program Helps Florida Customers Get Money Back for Making Home Improvements (ACCESSWIRE)
Feb-05-24 08:22AM	Duke Energy (DUK) to Post Q4 Earnings: What's in the Cards? (Zacks)
Feb-01-24 10:00AM	Duke Energy (DUK) Earnings Expected to Grow: Should You Buy? (Zacks)
08:50AM	Duke Energy Florida Donation Connects Pinellas County High School Students With Powerful Opportunity at St. Petersburg College (ACCESSWIRE)
Jan-31-24 03:11PM	Duke Energy provides resource plan update to South Carolina regulators that reflects state's booming population, economy (PR Newswire)
10:17AM	Duke Energy Florida to file for new base rates, expects lower overall customer bills in 2025 (PR Newswire)
06:44AM	Duke Energy (DUK) Offers EV Charger Rental in North Carolina (Zacks)
Jan-30-24 09:15AM	Duke Energy Carolinas Receives Approval for New Rates in North Carolina, Implements New Programs To Help Customers (ACCESSWIRE)
Jan-29-24 06:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
02:20PM	Duke Energy launches EV charger rental program in North Carolina (PR Newswire)
Jan-26-24 07:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jan-25-24 09:46AM	Duke Energy's rebates program helps Florida customers get money back for making home improvements (PR Newswire)
Jan-24-24 08:15AM	Duke Energy Gives Away Trees To Celebrate Florida Arbor Day (ACCESSWIRE)
Jan-18-24 10:45AM	Duke Energy Florida donation connects Pinellas County high school students with powerful opportunity at St. Petersburg College (PR Newswire)

Duke Energy Corp. engages in the distribution of natural gas and energy related services. It operates through the following segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Other. The Electric Utilities and Infrastructure segment conducts operations in regulated electric utilities in the Carolinas, Florida and the Midwest. The Gas Utilities and Infrastructure segment focuses on Piedmont, natural gas local distribution companies in Ohio and Kentucky, and natural gas storage and midstream pipeline investments. The Other segment includes interest expense on holding company debt, unallocated corporate costs, and Bison which is a wholly owned captive insurance company. The company was founded on April 30, 1904 and is headquartered in Charlotte, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Renjel Louis E.	EVP, External Affairs & Comm	Feb 12 '24	Sale	92.57	3,000	277,707	14,213	Feb 13 04:25 PM
Ghartey-Tagoe Kodwo	EVP, CLO & Corp Sec	Nov 21 '23	Sale	89.76	2,500	224,400	22,210	Nov 22 03:34 PM
MCKEE E MARIE	Director	Aug 17 '23	Sale	91.06	1,785	162,542	0	Aug 18 04:38 PM
Ghartey-Tagoe Kodwo	EVP, CLO & Corp Sec	Aug 16 '23	Sale	91.43	2,500	228,575	24,710	Aug 18 04:41 PM

Open in Screener

NTLA

Intellia Therapeutics Inc

May 03 • 03:04PM ET

23.51

Dollar change +0.24
Percentage change 1.03	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NTLA Intellia Therapeutics Inc daily Stock Chart

Held by: ARKK VTI VB ARKG IWM VXF VBK IWN IBB XT

Index	RUT	P/E	-	EPS (ttm)	-5.42	Insider Own	2.33%	Shs Outstand	96.44M	Perf Week	13.25%
Market Cap	2.27B	Forward P/E	-	EPS next Y	-5.64	Insider Trans	-2.32%	Shs Float	94.19M	Perf Month	-5.85%
Income	-481.19M	PEG	-	EPS next Q	-1.37	Inst Own	88.64%	Short Float	15.49%	Perf Quarter	-7.04%
Sales	36.27M	P/S	62.51	EPS this Y	-1.29%	Inst Trans	-0.30%	Short Ratio	9.85	Perf Half Y	-7.81%
Book/sh	11.29	P/B	2.08	EPS next Y	-2.69%	ROA	-34.11%	Short Interest	14.59M	Perf Year	-39.06%
Cash/sh	9.46	P/C	2.49	EPS next 5Y	30.00%	ROE	-42.10%	52W Range	19.37 - 47.48	Perf YTD	-22.89%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-22.30%	ROI	-41.96%	52W High	-50.49%	Beta	1.85
Dividend TTM	-	Quick Ratio	8.67	Sales past 5Y	12.09%	Gross Margin	75.26%	52W Low	21.37%	ATR (14)	1.32
Dividend Ex-Date	-	Current Ratio	8.67	EPS Y/Y TTM	12.31%	Oper. Margin	-1420.51%	RSI (14)	50.43	Volatility	6.57% 4.87%
Employees	526	Debt/Eq	0.11	Sales Y/Y TTM	-30.40%	Profit Margin	-1326.51%	Recom	1.54	Target Price	69.57
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-4.64%	Payout	-	Rel Volume	0.68	Prev Close	23.27
Sales Surprise	-115.04%	EPS Surprise	-1.49%	Sales Q/Q	-114.12%	Earnings	May 09 BMO	Avg Volume	1.48M	Price	23.51
SMA20	3.57%	SMA50	-9.93%	SMA200	-22.10%	Trades		Volume	866,801	Change	1.03%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-23-24	Downgrade	Goldman	Buy → Neutral	$136 → $32
Feb-15-24	Initiated	Wolfe Research	Peer Perform
Apr-13-23	Initiated	Canaccord Genuity	Buy	$66
Mar-21-23	Initiated	Bernstein	Outperform	$54
Mar-14-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$54 → $57
Feb-01-23	Initiated	Cantor Fitzgerald	Overweight	$67
Jan-24-23	Upgrade	Citigroup	Sell → Neutral	$48 → $39
Jan-19-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Oct-11-22	Initiated	Morgan Stanley	Overweight	$84
Sep-21-22	Initiated	JP Morgan	Overweight	$85
Sep-01-22	Initiated	Citigroup	Sell	$50
Jun-17-22	Initiated	BMO Capital Markets	Market Perform	$54
Jun-16-22	Initiated	BofA Securities	Buy	$70
Apr-28-22	Initiated	Credit Suisse	Outperform	$100
Feb-18-22	Initiated	William Blair	Outperform	$144
Feb-07-22	Upgrade	Oppenheimer	Perform → Outperform	$145 → $150
Jan-31-22	Initiated	Cowen	Outperform
Jan-07-22	Initiated	Piper Sandler	Overweight	$171
Oct-05-21	Initiated	Guggenheim	Buy	$170
Sep-24-21	Initiated	Stifel	Buy	$173

Show Previous Ratings

Today 02:18PM	Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street's Radar (InvestorPlace)
May-02-24 07:30AM	Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates (GlobeNewswire)
06:04AM	3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 07:30AM	Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024 (GlobeNewswire) +5.88%
Apr-25-24 11:21AM	Intellia (NTLA) to Report Q1 Earnings: What's in the Cards? (Zacks) -5.43%
10:01AM	Loading…
10:01AM	Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline (Zacks)
Apr-14-24 05:55AM	2 Stocks Down 30% to Buy Right Now (Motley Fool)
Apr-12-24 04:50AM	Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week. (Motley Fool)
Apr-09-24 04:50AM	Bull Market and Beyond: 3 Stocks Just Waiting to Soar (Motley Fool)
Mar-28-24 05:55AM	Better Cathie Wood Stock: Moderna vs. Intellia (Motley Fool)
Mar-21-24 05:29PM	Hot Stocks: The 3 Best Opportunities for Investing in Biotech (InvestorPlace)
04:19PM	3 Stocks That Could Be the Next Big Thing in Gene Editing (InvestorPlace)
Mar-19-24 01:06PM	Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study (Zacks)
Mar-18-24 07:30AM	Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy (GlobeNewswire)
Mar-09-24 09:45AM	Is Intellia Therapeutics Stock a Buy Now? (Motley Fool)
10:35AM	Loading…
Mar-06-24 10:35AM	Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst (Motley Fool)
Mar-01-24 01:43PM	Analyst Report: Intellia Therapeutics, Inc. (Morningstar Research)
Feb-29-24 05:50AM	A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now (Motley Fool)
Feb-28-24 09:30AM	Intellia Therapeutics, Inc. (NTLA) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks) +5.74%
Feb-27-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +12.15%
09:35AM	Intellia Therapeutics, Inc. (NTLA) Just Overtook the 20-Day Moving Average (Zacks)
Feb-23-24 12:22PM	Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:12AM	Intellia (NTLA) Beats on Q4 Earnings, Provides Pipeline Update (Zacks)
09:55AM	Wall Street Analysts See an 185.54% Upside in Intellia Therapeutics, Inc. (NTLA): Can the Stock Really Move This High? (Zacks)
Feb-22-24 10:53PM	Q4 2023 Intellia Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
08:12AM	Intellia Therapeutics Inc (NTLA) Reports Full-Year 2023 Financial Results and Operational Progress (GuruFocus.com)
07:30AM	Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Feb-20-24 05:02AM	Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought (Motley Fool)
Feb-17-24 01:59AM	Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen? (Motley Fool)
Feb-15-24 10:00AM	Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
07:30AM	Loading…
07:30AM	Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis (GlobeNewswire)
06:20AM	Intellia, ReCode partner on genetic medicines for cystic fibrosis (BioPharma Dive)
Feb-14-24 07:30AM	Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates (GlobeNewswire) +6.92%
Feb-13-24 06:05AM	3 Gene Editing Stocks With Unprecedented Surge Potential (InvestorPlace) -10.67%
Feb-10-24 05:09PM	Top 11 CRISPR Stocks To Invest In (Insider Monkey)
Feb-08-24 01:15PM	The 3 Most Undervalued Biotech Stocks to Buy in February 2024 (InvestorPlace) +5.37%
Feb-07-24 11:50AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Feb-05-24 05:25AM	A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist (Motley Fool)
Jan-31-24 05:00PM	Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine (GlobeNewswire)
12:28PM	3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential (InvestorPlace)
Jan-30-24 05:10AM	History Says the S&P 500 May Climb in the Triple Digits During This Bull Market. 3 Top Growth Stocks to Buy Before it Does. (Motley Fool) -6.07%
Jan-29-24 09:35AM	Down -19.06% in 4 Weeks, Here's Why Intellia Therapeutics, Inc. (NTLA) Looks Ripe for a Turnaround (Zacks) +6.08%
Jan-27-24 01:25PM	2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street (Motley Fool)
08:55AM	Is It Too Late to Buy Intellia Therapeutics Stock? (Motley Fool)
Jan-24-24 07:00AM	SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa (GlobeNewswire)
Jan-22-24 05:41PM	3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024 (InvestorPlace)
Jan-21-24 08:00AM	Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics (Motley Fool)
Jan-18-24 11:50AM	Is it a Good Idea to Invest in Intellia (NTLA) Stock Now? (Zacks)
Jan-13-24 06:05AM	The Top Healthcare Stocks to Buy With $100 (Motley Fool)
Jan-12-24 08:44AM	Is Intellia Therapeutics (NTLA) Stock a Solid Choice Right Now? (Zacks)
Jan-08-24 07:45AM	Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics (Motley Fool) +5.03%
05:52AM	4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024 (Motley Fool)
Jan-05-24 10:04AM	Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts (InvestorPlace)
Jan-04-24 04:01PM	Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones (GlobeNewswire)
12:47PM	Intellia to lay off staff, cut some early research (BioPharma Dive)
Dec-31-23 08:45AM	2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics (Motley Fool)
Dec-27-23 06:41PM	13 Most Promising Future Stocks To Buy According To Hedge Funds (Insider Monkey)
Dec-16-23 05:00AM	5 Beaten-Down Stocks That Could Soar in 2024 (Motley Fool)
Dec-13-23 05:20AM	3 Gene-Editing Stocks With the Potential to Mint Millionaires (InvestorPlace) +7.96%
Dec-12-23 06:00AM	Could Intellia Therapeutics Become the Next CRISPR Therapeutics? (Motley Fool)
Dec-10-23 11:57AM	5 Best Genomics Stocks To Buy Now (Insider Monkey)
Nov-28-23 05:30AM	2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market (Motley Fool)
Nov-24-23 07:00AM	Gene Editing Will Change Medicineand Maybe Health Investing Too (The Wall Street Journal)
Nov-15-23 11:07AM	Intellia (NTLA) Rises on EC's Orphan Drug Tag for HAE Candidate (Zacks)
Nov-14-23 07:30AM	Intellia Therapeutics Receives European Union Orphan Drug Designation for NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (GlobeNewswire) +11.09%
Nov-10-23 05:38PM	Analyst Report: Intellia Therapeutics, Inc. (Morningstar Research)
06:30AM	Intellia (NTLA) Beats on Q3 Earnings, Provides Pipeline Update (Zacks)
Nov-09-23 04:06PM	Market Today: Tech Stocks Under Pressure Amid Mixed Earnings and Fed Remarks (GuruFocus.com) -12.27%
03:37PM	3 Biotech Stocks That Are Betting on the Future of Gene Editing (InvestorPlace)
08:29AM	Intellia Therapeutics Inc (NTLA) Reports Q3 2023 Financial Results and Progress in CRISPR Therapies (GuruFocus.com)
07:30AM	Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress (GlobeNewswire)
Nov-06-23 08:02AM	Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners (Investor's Business Daily)
Nov-02-23 07:00AM	Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting (GlobeNewswire)
06:45AM	1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years (Motley Fool)
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
10:00AM	Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-28-23 07:30AM	Intellia Therapeutics Will Soon Make Biotech History. Is the Stock a Buy? (Motley Fool)
Oct-26-23 10:02AM	Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:30AM	Intellia Therapeutics to Present Updated Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis and Hold Conference Call to Discuss Third Quarter 2023 Earnings in November (GlobeNewswire)
Oct-23-23 09:40AM	Intellia (NTLA) Focuses on Developing Gene-Editing Therapies (Zacks)
08:45AM	3 Stocks Cathie Wood Is Buying That Should Be on Your List Too (Motley Fool)
Oct-21-23 05:00AM	Cathie Wood Is Buying These Top Growth Stocks -- and Both Could Make You Richer Over Time (Motley Fool)
Oct-19-23 11:46AM	Intellia's (NTLA) IND for Gene-Editing Therapy Gets FDA Clearance (Zacks)
Oct-18-23 04:10PM	Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing (Investor's Business Daily)
07:00AM	Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application to Initiate a Pivotal Phase 3 Trial of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy (GlobeNewswire)
Oct-16-23 12:39PM	Intellia's (NTLA) HAE Candidate Gets EMA's PRIME Designation (Zacks)
10:43AM	16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Woods Portfolio (Insider Monkey)
Oct-14-23 12:20PM	2 Growth Stocks That Could Deliver Parabolic Returns in Under 5 Years (Motley Fool)
Oct-13-23 08:38AM	Intellia Therapeutics Receives Priority Medicines (PRIME) Designation From the European Medicines Agency for NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (GlobeNewswire)
Oct-12-23 08:57AM	2 Brilliant Growth Stocks to Buy and Hold Forever (Motley Fool)
Oct-10-23 02:00PM	Down 45%, Is Intellia a Buy? (Motley Fool)
10:07AM	This Cathie Wood Stock Is Poised to Double, Says Wall Street (Motley Fool)
Oct-06-23 04:59AM	The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and Moderna (Zacks)
Oct-05-23 09:15AM	This Market-Beating Stock Just Gave Investors More Reasons to Invest (Motley Fool) +5.43%
Oct-04-23 09:27AM	Intellia (NTLA), Regeneron Expand Deal for Gene-Editing Therapies (Zacks)
Oct-03-23 10:07AM	Intellia Therapeutics Could Rise 167%, Per Wall Street, But Is It a Buy? (Motley Fool)
07:58AM	UPDATE 1-Regeneron, Intellia to make gene editing therapies in expanded collaboration (Reuters)
07:08AM	Regeneron, Intellia Therapeutics expand research collaboration to make gene editing therapies (Reuters)
07:00AM	Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases (GlobeNewswire)
Sep-23-23 09:45AM	Better Gene Editing Stock: Intellia Therapeutics vs. Rocket Pharmaceuticals (Motley Fool)

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BASTA JAMES	EVP, General Counsel	Mar 04 '24	Sale	32.99	2,297	75,778	81,571	Mar 05 04:10 PM
Clark Eliana	EVP, Chief Technical Officer	Mar 04 '24	Sale	32.99	605	19,959	71,470	Mar 05 04:10 PM
Sepp-Lorenzino Laura	EVP, Chief Scientific Officer	Jan 08 '24	Sale	28.87	2,275	65,682	43,927	Jan 10 04:15 PM
LEONARD JOHN M	President and CEO	Jan 03 '24	Sale	29.46	19,223	566,310	846,486	Jan 05 04:51 PM
Lebwohl David	EVP, Chief Medical Officer	Jan 03 '24	Sale	29.46	5,843	172,135	54,372	Jan 05 04:50 PM
Sepp-Lorenzino Laura	EVP, Chief Scientific Officer	Jan 03 '24	Sale	29.46	5,532	162,973	46,202	Jan 05 04:50 PM
Goddard Glenn	EVP, Chief Financial Officer	Jan 03 '24	Sale	29.46	5,365	158,053	40,585	Jan 05 04:49 PM
Clark Eliana	EVP, Chief Technical Officer	Jan 03 '24	Sale	29.50	4,608	135,954	40,845	Jan 05 04:44 PM
Hicks Derek	EVP, Chief Business Officer	Jan 03 '24	Sale	29.46	3,877	114,216	36,987	Jan 05 04:46 PM
BASTA JAMES	EVP, General Counsel	Jan 03 '24	Sale	29.46	3,805	112,095	51,474	Jan 05 04:45 PM
Bhanji Muna	Director	Oct 31 '23	Sale	23.90	265	6,334	11,996	Nov 02 04:42 PM
Bhanji Muna	Director	Jul 31 '23	Sale	42.33	265	11,217	12,261	Aug 02 05:19 PM
Bhanji Muna	Director	Jul 06 '23	Sale	39.30	1,867	73,373	12,526	Jul 10 05:21 PM
Clark Eliana	EVP, Chief Technical Officer	Jul 03 '23	Sale	40.51	360	14,584	45,146	Jul 06 03:34 PM
Clark Eliana	EVP, Chief Technical Officer	Jun 20 '23	Option Exercise	12.27	5,000	61,350	50,146	Jun 22 05:52 PM
Clark Eliana	EVP, Chief Technical Officer	Jun 20 '23	Sale	45.00	5,000	225,000	45,146	Jun 22 05:52 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

BIIB

Biogen Inc

ILMN

Illumina Inc

DUK

Duke Energy Corp.

NTLA

Intellia Therapeutics Inc

Upgrade your FINVIZ experience